CRNX catalysts
Catalysts and events linked to CRNX, newest first.
Do these developments change your position?
Review CRNX alongside your other holdings and identify which decision deserves attention first.
Review your initial audit before choosing ongoing portfolio scanning at $79/month.
DateCardAvg 5d
- 2026-07-08Vertex to Acquire Crinetics for $10B at 102% Premium to Expand Rare Disease PortfolioCRNX XPH
- 2026-07-08Vertex to Acquire Crinetics for $10B at 102% Premium to Expand Rare Disease PortfolioCRNX VRTX XPH-4.28%
- 2026-07-08Vertex to Acquire Crinetics for $10B at 102% PremiumCRNX VRTX-4.28%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.